Literature DB >> 25766761

Interplay between the Virus and Host in Rift Valley Fever Pathogenesis.

Kaori Terasaki1, Shinji Makino.   

Abstract

Rift Valley fever virus (RVFV) belongs to the genus Phlebovirus, family Bunyaviridae, and carries single-stranded tripartite RNA segments. The virus is transmitted by mosquitoes and has caused large outbreaks among ruminants and humans in sub-Saharan African and Middle East countries. The disease is characterized by a sudden onset of fever, headache, muscle pain, joint pain, photophobia, and weakness. In most cases, patients recover from the disease after a period of weeks, but some also develop retinal or macular changes, which result in vision impairment that lasts for an undefined period of time, and severe disease, characterized by hemorrhagic fever or encephalitis. The virus also causes febrile illness resulting in a high rate of spontaneous abortions in ruminants. The handling of wild-type RVFV requires high-containment facilities, including biosafety level 4 or enhanced biosafety level 3 laboratories. Nonetheless, studies clarifying the mechanisms of the RVFV-induced diseases and preventing them are areas of active research throughout the world. By primarily referring to recent studies using several animal model systems, protein expression systems, and specific mutant viruses, this review describes the current knowledge about the mechanisms of pathogenesis of RVF and biological functions of various viral proteins that affect RVFV pathogenicity.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25766761      PMCID: PMC4551617          DOI: 10.1159/000373924

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  52 in total

1.  Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs.

Authors:  M Bouloy; C Janzen; P Vialat; H Khun; J Pavlovic; M Huerre; O Haller
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  The C-terminal region of Rift Valley fever virus NSm protein targets the protein to the mitochondrial outer membrane and exerts antiapoptotic function.

Authors:  Kaori Terasaki; Sungyong Won; Shinji Makino
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

3.  Aerosolized rift valley fever virus causes fatal encephalitis in african green monkeys and common marmosets.

Authors:  Amy L Hartman; Diana S Powell; Laura M Bethel; Amy L Caroline; Richard J Schmid; Tim Oury; Douglas S Reed
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

4.  The pathogenesis of Rift Valley fever virus in the mouse model.

Authors:  Darci R Smith; Keith E Steele; Joshua Shamblin; Anna Honko; Joshua Johnson; Christopher Reed; Maureen Kennedy; Jennifer L Chapman; Lisa E Hensley
Journal:  Virology       Date:  2010-09-17       Impact factor: 3.616

5.  Chemotaxis of T-cells after infection of human choroid plexus papilloma cells with Echovirus 30 in an in vitro model of the blood-cerebrospinal fluid barrier.

Authors:  Henriette Schneider; Claudia Ellen Weber; Julia Schoeller; Ulrike Steinmann; Julia Borkowski; Hiroshi Ishikawa; Peter Findeisen; Ortwin Adams; Ruediger Doerries; Christian Schwerk; Horst Schroten; Tobias Tenenbaum
Journal:  Virus Res       Date:  2012-09-19       Impact factor: 3.303

6.  IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus.

Authors:  Rajini Mudhasani; Julie P Tran; Cary Retterer; Sheli R Radoshitzky; Krishna P Kota; Louis A Altamura; Jeffrey M Smith; Beverly Z Packard; Jens H Kuhn; Julie Costantino; Aura R Garrison; Connie S Schmaljohn; I-Chueh Huang; Michael Farzan; Sina Bavari
Journal:  J Virol       Date:  2013-05-29       Impact factor: 5.103

7.  Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease.

Authors:  Brian H Bird; César G Albariño; Stuart T Nichol
Journal:  Virology       Date:  2007-04-06       Impact factor: 3.616

8.  Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice.

Authors:  Petrus Jansen van Vuren; Caroline T Tiemessen; Janusz T Paweska
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

9.  Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse.

Authors:  Kimberly K Gray; Melissa N Worthy; Terry L Juelich; Stacy L Agar; Allison Poussard; Dan Ragland; Alexander N Freiberg; Michael R Holbrook
Journal:  PLoS Negl Trop Dis       Date:  2012-02-28

10.  Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice.

Authors:  Céline Gommet; Agnès Billecocq; Grégory Jouvion; Milena Hasan; Tânia Zaverucha do Valle; Laurent Guillemot; Charlène Blanchet; Nico van Rooijen; Xavier Montagutelli; Michèle Bouloy; Jean-Jacques Panthier
Journal:  PLoS Negl Trop Dis       Date:  2011-12-06
View more
  9 in total

1.  Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin.

Authors:  Kumari G Lokugamage; Krishna Narayanan; Keisuke Nakagawa; Kaori Terasaki; Sydney I Ramirez; Chien-Te K Tseng; Shinji Makino
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  A strand-specific real-time quantitative RT-PCR assay for distinguishing the genomic and antigenomic RNAs of Rift Valley fever phlebovirus.

Authors:  Breanna Tercero; Kaori Terasaki; Keisuke Nakagawa; Krishna Narayanan; Shinji Makino
Journal:  J Virol Methods       Date:  2019-07-14       Impact factor: 2.014

3.  Characterization of the Molecular Interactions That Govern the Packaging of Viral RNA Segments into Rift Valley Fever Phlebovirus Particles.

Authors:  Breanna Tercero; Krishna Narayanan; Kaori Terasaki; Shinji Makino
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

Review 4.  Rift Valley fever: biology and epidemiology.

Authors:  Daniel Wright; Jeroen Kortekaas; Thomas A Bowden; George M Warimwe
Journal:  J Gen Virol       Date:  2019-07-16       Impact factor: 5.141

5.  Mechanistic Insight into the Host Transcription Inhibition Function of Rift Valley Fever Virus NSs and Its Importance in Virulence.

Authors:  Kaori Terasaki; Sydney I Ramirez; Shinji Makino
Journal:  PLoS Negl Trop Dis       Date:  2016-10-06

Review 6.  Potential of Using Capripoxvirus Vectored Vaccines Against Arboviruses in Sheep, Goats, and Cattle.

Authors:  Mahder Teffera; Shawn Babiuk
Journal:  Front Vet Sci       Date:  2019-12-20

7.  NSG-Mice Reveal the Importance of a Functional Innate and Adaptive Immune Response to Overcome RVFV Infection.

Authors:  Lukas Mathias Michaely; Melanie Rissmann; Markus Keller; Rebecca König; Felicitas von Arnim; Martin Eiden; Karl Rohn; Wolfgang Baumgärtner; Martin Groschup; Reiner Ulrich
Journal:  Viruses       Date:  2022-02-08       Impact factor: 5.048

8.  NSs Virulence Factor of Rift Valley Fever Virus Engages the F-Box Proteins FBXW11 and β-TRCP1 To Degrade the Antiviral Protein Kinase PKR.

Authors:  Markus Kainulainen; Simone Lau; Charles E Samuel; Veit Hornung; Friedemann Weber
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

9.  Exosomes originating from infection with the cytoplasmic single-stranded RNA virus Rift Valley fever virus (RVFV) protect recipient cells by inducing RIG-I mediated IFN-B response that leads to activation of autophagy.

Authors:  Farhang Alem; Adeyemi A Olanrewaju; Samson Omole; Heather E Hobbs; Noor Ahsan; Graham Matulis; Christine A Brantner; Weidong Zhou; Emanuel F Petricoin; Lance A Liotta; Massimo Caputi; Sina Bavari; Yuntao Wu; Fatah Kashanchi; Ramin M Hakami
Journal:  Cell Biosci       Date:  2021-12-25       Impact factor: 7.133

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.